Tech Exchange with Molecubes (a Bruker company)

When: June 5, 2026 14:00–14:30 CEST
Presented by: Katarzyna Desroques

Katarzyna Desrocques, from Molecubes (a Bruker company), will present on "Lowering the barrier to nuclear molecular imaging and its value in preclinical research - X-CUBE, ɣ-CUBE and β-CUBE – Bruker Benchtop Nuclear Imaging Platform."

Abstract

At Molecubes a Bruker Company, we believe that molecular imaging should be accessible to every research lab. We therefore made it our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions called Cubes with the highest performance, supported by fast and simple workflows.

Photos of the X-CUBE, ɣ-CUBE and β-CUBE – Bruker Benchtop Nuclear Imaging Platforms. Courtesy: Molecubes, a Bruker Company.

This webinar will highlight the added value of nuclear in vivo imaging as a non-invasive method for monitoring biological processes within the living animal body. Nuclear imaging is widely used across a range of applications, including oncology, neurology, drug development, pharmacokinetics, theranostics, and more.

Images highlighting preclinical PET, SPECT and CT applications. Courtesy: Molecubes, a Bruker Comapny.

The webinar will also present concrete application examples demonstrating how these imaging techniques contribute to research and development in both preclinical and translational settings.

Event details